Authors: | Ravandi, F.; Ritchie, E. K.; Sayar, H.; Lancet, J. E.; Craig, M. D.; Vey, N.; Strickland, S. A.; Schiller, G. J.; Jabbour, E.; Erba, H. P.; Pigneux, A.; Horst, H. A.; Recher, C.; Klimek, V. M.; Cortes, J.; Roboz, G. J.; Craig, A. R.; Fox, J. A.; Ward, R.; Smith, J. A.; Acton, G.; Mehta, C.; Kantarjian, H. M.; Stuart, R. K. |
Abstract Title: | Improved survival in patients ≥60 with first relapsed/refractory acute myeloid leukemia treated with vosaroxin plus cytarabine vs placebo plus cytarabine: Results from the phase 3 valor study |
Meeting Title: | 20th Congress of the European Hematology Association (EHA) |
Journal Title: | Haematologica |
Volume: | 100 |
Issue: | Suppl. 1 |
Meeting Dates: | 2015 Jun 11-14 |
Meeting Location: | Vienna, Austria |
ISSN: | 0390-6078 |
Publisher: | Ferrata Storti Foundation |
Date Published: | 2015-06-01 |
Start Page: | 46 |
End Page: | 47 |
Language: | English |
ACCESSION: | WOS:000361204901097 |
PROVIDER: | wos |
PMCID: | PMC4480587 |
Notes: | Meeting Abstract: P197 -- Source: Wos |